Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for HIND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 6.048M
March 31, 2026 6.744M
December 31, 2025 2.442M
September 30, 2025 2.530M
June 30, 2025 5.829M
March 31, 2025 1.23M
December 31, 2024 -4.391M
September 30, 2024 1.487M
June 30, 2024 3.035M
March 31, 2024 4.534M
December 31, 2023 6.663M
September 30, 2023 3.083M
June 30, 2023 6.738M
March 31, 2023 7.758M
December 31, 2022 3.661M
September 30, 2022 20.94M
June 30, 2022 32.36M
March 31, 2022 38.62M
December 31, 2021 44.33M
September 30, 2021 79.22M
Date Value
June 30, 2021 58.12M
March 31, 2021 10.10M
December 31, 2020 14.49M
September 30, 2020 5.922M
June 30, 2020 7.178M
March 31, 2020 11.07M
December 31, 2019 15.85M
September 30, 2019 20.06M
June 30, 2019 8.387M
March 31, 2019 6.518M
December 31, 2018 13.11M
September 30, 2018 20.15M
June 30, 2018 16.05M
March 31, 2018 24.42M
December 31, 2017 35.11M
September 30, 2017 43.52M
June 30, 2017 50.22M
March 31, 2017 57.07M
December 31, 2016 64.30M
September 30, 2016 3.405M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Cardiac Biotech Solutions, Inc. -2.221M
Anika Therapeutics, Inc. 137.28M
Enovis Corp. 1.477B
Edwards Lifesciences Corp. 10.62B
Perspective Therapeutics, Inc. 323.86M

Shareholders Equity (Quarterly) Related Metrics